News
Merck's pneumococcal vaccine showed strong immune responses in children and teens who are at higher risk of serious illness ...
An estimated 14 million kids don't get any vaccines. They face serious threats from measles, diarrhea, pneumonia and more.
Merck (NYSE:MRK) announced late-stage trial data on Thursday suggesting that its Capvaxive vaccine, indicated for adults to prevent invasive pneumococcal disease and pneumonia, is also effective in ...
Neuman and coworkers conducted a prospective cohort study to try to add to what is known about predictive factors for a diagnosis of pneumonia in children seen in the emergency department (ED). The ...
Children with uncomplicated pneumonia should be treated with shorter courses of antibiotics after updated NICE guidance was ...
The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization ...
Researchers derived pragmatic models that accurately distinguish mild, moderate and severe pneumonia in children, based on evidence from a study performed in 73 Emergency Departments (EDs) in 14 ...
Penicillin V matches amoxicillin in reducing the hospitalisation risk for lower respiratory tract infection and all-cause mortality among patients with pneumonia attending primary care.
The Canadian Press on MSN1d
ER visits for pneumonia doubled last fall, CIHI data shows
The number of emergency department visits for pneumonia more than doubled last fall over the previous year, the Canadian ...
Political bluster about vaccines has arrived along with the season for getting vaccinated against diseases that can lead to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results